Tivozanib Impurity 14 | CAS 1622343-01-4 - Request Quote
Tivozanib Impurity 14
| SZ CAT No: | SZ-T099016 |
| CAS No | 1622343-01-4 |
| Mol.F. | C21H17ClN4O5 |
| Mol.Wt. | 440.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tivozanib Impurity 14 is chemically 1-(2-Chloro-4-((7-hydroxy-6-methoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea. Tivozanib Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Tivozanib Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tivozanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1622343-01-4
Purchase 1622343-01-4
Order 1622343-01-4
Enquire 1622343-01-4
price of 1622343-01-4
1622343-01-4 Supplier
1622343-01-4 Manufacturer
1622343-01-4 Exporter
buy high quality Tivozanib Impurity 14
Purchase Tivozanib Impurity 14
Tivozanib Impurity 14 suppliers
Tivozanib Impurity 14 manufacturers
Tivozanib Impurity 14 price
Order Tivozanib Impurity 14
Enquire Tivozanib Impurity 14
Tivozanib Impurity 14 cost
Tivozanib Impurity 14 Supplier
Tivozanib Impurity 14 Distributor
Tivozanib Impurity 14 for Method Validation
Tivozanib Reference Standard
Tivozanib Impurity 14 for ANDA Filing
Tivozanib Impurity 14 for Forced Degradation Studies
Tivozanib Impurity 14 Identification Standards
Tivozanib Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


